Mesoridazine besylate - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for mesoridazine besylate and what is the scope of freedom to operate?

Mesoridazine besylate is the generic ingredient in one branded drug marketed by Novartis and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for mesoridazine besylate.

Summary for mesoridazine besylate

US Patents:	0
Tradenames:	1
Applicants:	1
NDAs:	3
Drug Master File Entries:	2
Raw Ingredient (Bulk) Api Vendors:	52
Patent Applications:	2,577
DailyMed Link:	mesoridazine besylate at DailyMed

Medical Subject Heading (MeSH) Categories for mesoridazine besylate

Antipsychotic Agents
Dopamine Antagonists

Anatomical Therapeutic Chemical (ATC) Classes for mesoridazine besylate

N05AC	Phenothiazines with piperidine structure
N05A	ANTIPSYCHOTICS
N05	PSYCHOLEPTICS
N	Nervous system

US Patents and Regulatory Information for mesoridazine besylate

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Novartis	SERENTIL	mesoridazine besylate	TABLET;ORAL	016774-002	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Novartis	SERENTIL	mesoridazine besylate	TABLET;ORAL	016774-004	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Novartis	SERENTIL	mesoridazine besylate	INJECTABLE;INJECTION	016775-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.